- Home
- QNCX vs ORMP Comparison
QNCX vs ORMP Comparison
Compare QNCX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- ORMP
- Stock Information
- Founded
- QNCX 2012
- ORMP 2002
- Country
- QNCX United States
- ORMP United States
- Employees
- QNCX N/A
- ORMP N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- QNCX Health Care
- ORMP Health Care
- Exchange
- QNCX Nasdaq
- ORMP Nasdaq
- Market Cap
- QNCX 90.8M
- ORMP 90.2M
- IPO Year
- QNCX 2019
- ORMP N/A
- Fundamental
- Price
- QNCX $1.60
- ORMP $2.41
- Analyst Decision
- QNCX Strong Buy
- ORMP Hold
- Analyst Count
- QNCX 6
- ORMP 1
- Target Price
- QNCX $8.00
- ORMP N/A
- AVG Volume (30 Days)
- QNCX 124.9K
- ORMP 99.1K
- Earning Date
- QNCX 11-12-2025
- ORMP 11-06-2025
- Dividend Yield
- QNCX N/A
- ORMP N/A
- EPS Growth
- QNCX N/A
- ORMP N/A
- EPS
- QNCX N/A
- ORMP N/A
- Revenue
- QNCX N/A
- ORMP $2,000,000.00
- Revenue This Year
- QNCX N/A
- ORMP N/A
- Revenue Next Year
- QNCX N/A
- ORMP N/A
- P/E Ratio
- QNCX N/A
- ORMP N/A
- Revenue Growth
- QNCX N/A
- ORMP N/A
- 52 Week Low
- QNCX $0.69
- ORMP $1.82
- 52 Week High
- QNCX $2.45
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- QNCX 47.89
- ORMP 71.70
- Support Level
- QNCX $1.56
- ORMP $2.17
- Resistance Level
- QNCX $1.65
- ORMP $2.45
- Average True Range (ATR)
- QNCX 0.08
- ORMP 0.06
- MACD
- QNCX 0.00
- ORMP 0.03
- Stochastic Oscillator
- QNCX 64.65
- ORMP 88.24
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.